Search

Search Results
Results 6761 - 6770 of 7236 for parkinson
  • Drug - 27 Mar 2023
    Consumer Medicine Information (CMI) about Abisart HCTZ intended for persons living in Australia.
  • Health - 14 Mar 2023
    Dance is a form of performing art wherein the body moves in a rhythmic way, usually to express feelings or ideas. Dancing has shown many health benefits, including boosting brain power and function.
  • Health - 10 Mar 2023
    Binswanger disease, also known as Binswanger encephalopathy and subcortical dementia is a progressive neurological condition.
  • News - 3 Mar 2023
    Tens of thousands of patients across the country could benefit from quicker, earlier diagnoses and more effective treatments for a range of conditions - as the government invests nearly £16 million...
  • News - 21 Feb 2023
    Researchers presented eight hallmarks of neurodegenerative diseases (NDDs), their in vivo biomarkers, and interactions to help categorize NDDs and specify patients within a specific NDD.
  • Drug - 16 Feb 2023
    Consumer Medicine Information (CMI) about Solian intended for persons living in Australia.
  • Drug - 16 Feb 2023
    Consumer Medicine Information (CMI) about Amisulpride Winthrop intended for persons living in Australia.
  • Drug - 9 Feb 2023
    Consumer Medicine Information (CMI) about Rixadone Oral (Risperidone Oral solution 1mg/mL) intended for persons living in Australia.
  • News - 25 Jan 2023
    Marjorie Kruger was stunned to learn last fall that she would have to leave the nursing home where she'd lived comfortably for six years.
  • Drug - 24 Jan 2023
    Consumer Medicine Information (CMI) about Micardis Plus (telmisartan and hydrochlorothiazide) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.